Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-28
2011-06-28
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S283000
Reexamination Certificate
active
07968558
ABSTRACT:
The present invention concerns novel amidines derivatives of 2-heteroaryl-quinazoline and quinolines of general formula (I), to a process for their preparation, to their pharmaceutical compositions and to the use of these compounds, salts and solvates thereof, along with the corresponding pharmaceutical compositions, for the treatment of pain and inflammatory disorders. Compounds of this invention are extremely potent analgesics, suitable for the treatment of both inflammatory and neuropathic pain. Particularly for the treatment of neuropathic pain the compounds of the invention have been proved largely superior to the standards currently in the clinical use. These compounds are not acting through inhibition of COX or NOS enzymes but are effective in inhibiting inflammatory cytokine production induced by inflammatory stimuli.
REFERENCES:
patent: 1 571 142 (2005-09-01), None
Morissette et al. “High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.” 2004, Advanced Drug Delivery Reviews, 56, 275-300.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 and 365.
Lowell O. Randall et al.; A Method for Measurement of Analgesic Activity on Inflamed Tissue; Department of Pharmacology Hoffman-La Roche, Inc.; CX 1; No. 4; 1957; p. 409.
C.J. Woolf, A., et al.; Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of turmor necrosis factor; Birtish Journal of Pharmacology; vol. 121, pp. 417-424; 1997.
Arthur Gomtsyan et al.; Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain: Structure-Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties; Journal of Medicinal Chemistry; vol. 48 (3), pp. 744-752, 2005.
Dajie Li et al.; Nitroarylastannanes as Synthons for the Preparation of Phenanthridine and Benzo[i]phenanthridine Derivatives; The Journal of Organic Chemistry; vol. 65(9); pp. 2802-2805; 2000.
Steinar Hunskaar et al.; The formalin test in mice: dissociation between inflammatory and non-inflammatory pain; Pain, vol. 30, pp. 103-114; 1987.
Reza Sharif Naeini et al.; Remodeling of spinal nociceptive mechanisms in an animal model of monoarthritis; European Journal of Neuroscience, vol. 22, pp. 2005-2015, 2005.
B.J. Broughton et al.; Antiallergic activity of 2-phenyl-8-azapurin-6-ones; Journal of Medicinal Chemistry; vol. 18(11), pp. 1117-1122; 1975.
H.O.J. Collier et al.; The abdominal constriction response and its suppression by analgesic drugs in the mouse; British Journal Pharmac, Chemother.; vol. 32, pp. 295-310; 1968.
Cheryl L. Stucky et al.; Mechanisms of Pain; From the Academy; vol. 98, No. 21; pp. 11845-11846; Oct. 9, 2001.
Enzo Cereda et al.; Synthesis and biological evaluation of new antimuscarinic compounds with amidine basic centers. A useful bioisosteric replacement of classical cationic heads; Journal of Medicinal Chemistry; vol. 33 No. 8; pp. 2108-2113; 1990.
Katharine Walker et al.; Animal models for pain research; Molecular Medicine Today; vol. 5, p. 319, Jul. 1999.
C. Courteix, et al.; Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain; Elsevier Science Publishers; vol. 53, pp. 81-88, 1993.
F.D. Bellamy, Selective Reduction of Aromatic Nitro Compounds with Stannous Chloride in Non Acidic and Non Aqueous Medium; Tetrahedron Letter, vol. 25, No. 8, pp. 839-842, 1984.
Masanori Kosugi et al.; Preparation of Aryltributyltin Having Electron-withdrawing Group by Palladium Catalyzed Reaction of Hexabutylditin with Aryl Iodide; The Chemical Society of Japan; vol. 56, pp. 3855-3856, 1983.
Mercedes Amat et al.; Palladium (0)-Catalyzed Heteroarylation of 2-and 3-Indolylzinc Derivatives. An Efficient General Method for the Preparation of (2-Pyridyl)indoles and Their Application to Indole Alkaloid Synthesis; The Journal of Organic Chemistry; vol. 62, No. 10, pp. 3158-3175; May 16, 1997.
S.T. Meller et al.; The Possible Role of Glia in Nociceptive Processing and Hyperalgesia in the Spinal Cord of the Rat; Neuropharmacology, vol. 33, No. 11, pp. 1471-1478, 1994.
Frances V. Abbott et al.; The formalin test: scoring properties of the first and second phases of the pain response in rats; Elsevier Science; vol. 60; pp. 91-102; 1995.
Barry G. Shearer et al.; S-2-Naphthylmethyl Thioacetimidate Hydrobromide: A new odorless Reagent for the Mild Synthesis of Substituted Acetamidines; Tetrahedron Letter, vol. 38, No. 2, pp. 179-182, 1997.
Dennis G. Hall; Boronic Acids; Preparation and Applications in Organic Synthesis and Medicine; Wiley-VCH Verlag GmbH & Co. KGaA; 2005.
Caselli Gianfranco
Fiorentino Teresa Simonetta
Giordani Antonio
Makovec Francesco
Mandelli Stefano
McDowell Brian
Rottapharm S.p.A.
Sughrue & Mion, PLLC
Wilson James O
LandOfFree
Amidine derivatives of 2-heteroaryl-quinazolines and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amidine derivatives of 2-heteroaryl-quinazolines and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidine derivatives of 2-heteroaryl-quinazolines and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2745760